Kandemir, Y. B. Et Al. 2019. Melatonin protects against streptozotocin-induced diabetic cardiomyopathy through the mammalian target of rapamycin (mTOR) signaling pathway. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE , vol.28, no.9 , 1171-1177.

Kandemir, Y. B., Tosun, V., & GÜNTEKİN, Ü., (2019). Melatonin protects against streptozotocin-induced diabetic cardiomyopathy through the mammalian target of rapamycin (mTOR) signaling pathway. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE , vol.28, no.9, 1171-1177.

Kandemir, Yasemin, Veysel Tosun, And ÜNAL GÜNTEKİN. "Melatonin protects against streptozotocin-induced diabetic cardiomyopathy through the mammalian target of rapamycin (mTOR) signaling pathway," ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE , vol.28, no.9, 1171-1177, 2019

Kandemir, Yasemin B. Et Al. "Melatonin protects against streptozotocin-induced diabetic cardiomyopathy through the mammalian target of rapamycin (mTOR) signaling pathway." ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE , vol.28, no.9, pp.1171-1177, 2019

Kandemir, Y. B. Tosun, V. And GÜNTEKİN, Ü. (2019) . "Melatonin protects against streptozotocin-induced diabetic cardiomyopathy through the mammalian target of rapamycin (mTOR) signaling pathway." ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE , vol.28, no.9, pp.1171-1177.

@article{article, author={Yasemin Behram Kandemir Et Al. }, title={Melatonin protects against streptozotocin-induced diabetic cardiomyopathy through the mammalian target of rapamycin (mTOR) signaling pathway}, journal={ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE}, year=2019, pages={1171-1177} }